PATUSKY CHRISTOPHER 4
4 · UNITED THERAPEUTICS Corp · Filed Jan 13, 2025
Insider Transaction Report
Form 4
PATUSKY CHRISTOPHER
Director
Transactions
- Exercise/Conversion
Common Stock
2025-01-10$175.43/sh+5,000$877,150→ 5,900 total - Sale
Common Stock
2025-01-10$362.03/sh−1,930$698,724→ 2,101 total - Sale
Common Stock
2025-01-10$361.04/sh−969$349,850→ 4,031 total - Sale
Common Stock
2025-01-10$363.86/sh−109$39,661→ 900 total - Sale
Common Stock
2025-01-10$358.65/sh−300$107,596→ 5,600 total - Sale
Common Stock
2025-01-10$359.82/sh−600$215,893→ 5,000 total - Sale
Common Stock
2025-01-10$362.95/sh−1,092$396,347→ 1,009 total - Exercise/Conversion
Stock Option
2025-01-10−5,000→ 5,000 totalExercise: $175.43From: 2016-06-26Exp: 2025-06-26→ Common Stock (5,000 underlying)
Holdings
- 1,100(indirect: By Trust)
Common Stock
Footnotes (7)
- [F1]This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024.
- [F2]This transaction was executed in multiple trades at prices ranging from $358.11 to $358.895. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $359.12 to $360.095. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price.
- [F4]This transaction was executed in multiple trades at prices ranging from $360.395 to $361.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price.
- [F5]This transaction was executed in multiple trades at prices ranging from $361.485 to $362.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price.
- [F6]This transaction was executed in multiple trades at prices ranging from $362.49 to $363.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price.
- [F7]This transaction was executed in multiple trades at prices ranging from $363.80 to $364.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price.